PetIQ, Inc. (NASDAQ:PETQ) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Katie Turner - IR Cord Christensen - Chairman and CEO Susan Sholtis - President John Newland - CFO Michael Smith - EVP, Product Segment Conference Call Participants David Westenberg - Guggenheim Securities Steph Wissink - Jefferies Jon Andersen - William Blair Joe Altobello - Raymond James Bill Chappell - Truist Securities Operator Welcome to the PetIQ, Inc., First Quarter 2021 Earnings conference call. Du ...

Smarter Pet Health First Quarter 2021 Earnings Presentation May 5, 2021 OUR MISSION: To deliver a smarter way for pet parents to help their pets live their best lives through convenient access to affordable products and services. | --- ...

Commission File Number: 001-38163 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PetIQ, Inc. (Exact name of registrant as specified in its charter) Delaware 35-2554312 (State or other jurisdiction o ...

PetIQ, Inc. (NASDAQ:PETQ) Q4 2020 Results Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Katie Turner - Investor Relations Cord Christensen - Chairman and CEO Susan Sholtis - President John Newland - Chief Financial Officer Conference Call Participants David Westenberg - Guggenheim Securities Joe Altobello - Raymond James Jon Andersen - William Blair Bill Chappell - Truist Securities Steph Wissink - Jefferies Brian Nagel - Oppenheimer Operator Thank you for standing by. This is t ...

Financial Performance - Consolidated net sales increased by approximately $70.7 million, or 10%, to $780.1 million for the year ended December 31, 2020, compared to $709.4 million for the year ended December 31, 2019 [205]. - The Products segment net sales were $725.7 million, representing 93.0% of total net sales, while Service revenue decreased to $54.3 million, accounting for 7.0% of total net sales [204]. - Gross profit increased to $135.2 million, with a gross margin of 17.3% for 2020, compared to 15.1% in 2019 [204]. - Net loss for the year ended December 31, 2020, was $81.0 million, compared to a net loss of $14.3 million in 2019, reflecting a significant increase in losses [204]. - EBITDA for the year ended December 31, 2020, was $22.4 million, an increase from $12.0 million in 2019, while Adjusted EBITDA rose to $67.8 million from $60.7 million [236]. - Comprehensive loss attributable to PetIQ was $77.1 million for 2020, compared to a loss of $11.2 million in 2019, highlighting the challenges faced during the year [309]. Expenses and Losses - General and administrative expenses as a percentage of net sales increased to 17.7% in 2020 from 14.5% in 2019, primarily due to integration costs and growth in corporate services [197]. - The operating loss for 2020 was $3.2 million, consistent with the previous year's loss of $3.1 million [204]. - Consolidated general and administrative expenses increased approximately $35.2 million, or 34%, to $138.4 million for the year ended December 31, 2020, compared to $103.1 million for the year ended December 31, 2019 [211]. - Interest expense, net, increased $11.8 million, to $26.3 million for the year ended December 31, 2020, compared to $14.5 million for the year ended December 31, 2019 [216]. - Pre-tax net loss increased $11.2 million to a pre-tax net loss of $28.8 million for the year ended December 31, 2020, compared to a pre-tax net loss of $17.6 million for the year ended December 31, 2019 [217]. Cash Flow and Investments - Cash and cash equivalents as of December 31, 2020, were $33.5 million, up from $27.3 million as of December 31, 2019 [238]. - Net cash used in operating activities was $4.6 million for the year ended December 31, 2020, compared to $20.8 million provided in 2019 [241]. - Net cash used in investing activities decreased to $118.0 million for the year ended December 31, 2020, from $195.0 million in 2019 [245]. - Net cash provided by financing activities was $128.8 million for the year ended December 31, 2020, compared to $135.1 million in 2019 [246]. Segment Performance - The Services segment experienced declining sales due to COVID-19 related closures, impacting overall revenue growth [207]. - Product sales increased approximately $108.6 million, or 18%, to $725.7 million for the year ended December 31, 2020, compared to $617.1 million for the year ended December 31, 2019 [208]. - Services segment Adjusted EBITDA decreased approximately $16.7 million, or 83.1%, to $3.4 million for the year ended December 31, 2020, compared to $20.0 million for the year ended December 31, 2019 [223]. Debt and Obligations - Total contractual obligations as of December 31, 2020 amounted to $621.8 million, with long-term debt comprising $419.8 million [268]. - The Company had variable rate debt of approximately $232.3 million under its Revolver and Term Loan as of December 31, 2020 [285]. - The Company entered into a guarantee note and Contingent Notes related to the VIP Acquisition, with a collective balance of $27.5 million [266]. - As of December 31, 2020, the company had $15.0 million outstanding under a revolving credit facility with a weighted average interest rate of 2.3% [257]. Assets and Capital - Total assets increased to $771.6 million in 2020, up from $672.7 million in 2019, driven by growth in current and non-current assets [305]. - Long-term debt, less current installments, rose to $356.0 million in 2020, compared to $251.4 million in 2019, indicating increased leverage [305]. - The company’s additional paid-in capital increased to $356.4 million in 2020, up from $300.1 million in 2019, reflecting ongoing capital raising efforts [305]. Tax and Deferred Assets - The company had $53.1 million in deferred tax assets associated with exchange transactions as of December 31, 2020 [297]. - The Company has recorded a valuation allowance against deferred tax assets, believing it is more likely than not that the benefit from these assets will not be realized [282]. - Income tax expense totaled (181.3%) and 18.8% of pretax earnings for the years ended December 31, 2020 and 2019, respectively [219]. Other Financial Metrics - Research and development costs amounted to $2.3 million, $1.3 million, and $0.2 million for the years ended December 31, 2020, 2019, and 2018, respectively [363]. - Advertising costs were $10.1 million, $4.5 million, and $2.9 million for the years ended December 31, 2020, 2019, and 2018, respectively [363]. - Stock options granted to executives and other employees are valued using the Black-Scholes option pricing model [366].

PetIQ, Inc. (NASDAQ:PETQ) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Katie Turner - Investor Relations Cord Christensen - Chairman and Chief Executive Officer Susan Sholtis - President John Newland - Chief Financial Officer Conference Call Participants Jon Andersen - William Blair Steph Wissink - Jefferies Bill Chappell - Truist Securities David Westenberg - Guggenheim Securities Operator Thank you for standing by. This is the conference operator. Welcome to the PetIQ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ, Inc. (Exact name of registrant as specified in its charter) Delaware 35-2554312 (State or other jurisdicti ...

S m a r t e r P e t H e a l t h Third Quarter 2020 Earnings Presentation November 5, 2020 OUR MISSION: To deliver a smarter way for pet parents to help their pets live their best lives through convenient access to affordable products and services. | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

PetIQ, Inc. (NASDAQ:PETQ) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Jeff Sonnek – ICR Cord Christensen – Chairman and Chief Executive Officer Susan Sholtis – President John Newland – Chief Financial Officer Conference Call Participants Joe Altobello – Raymond James David Westenberg – Guggenheim Securities Kevin Grundy – Jefferies Bill Chappell – Truist Jon Andersen – William Blair Operator Greetings. Welcome to the PetIQ Second Quarter 2020 Earnings Conference Call. At ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 For the transition period from to Commission File Number: 001-38163 PetIQ, Inc. (Exact name of registrant as specified in its charter) Delaware 35-2554312 (State or other jurisdiction of ...